Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...

Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...

AJ Mast / Bloomberg via Getty Images The S&P 500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's consumer price report. Eli Lilly ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... He anticipated that the S&P 500 would rise to approximately 7,000 by mid-2025 before retreating to around ...

Healthcare sector shows strong performance in January amid signs of a brighter 2025, according to analysts. Read more here.

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (NYSE ... outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so ...

Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4. All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq ...